Evidence for TGF-β-mediated 'defense' of the glomerulus: A blackguard molecule rehabilitated?

Experimental Nephrology

Volumn 6, Issue 1, 1998, Pages 1-6

  Kitamura, Masanori ^a   Fine, Leon G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apoptosis; Glomerulonephritis; Glomerulus; Macrophage; Mitosis; Neutrophil; Nitric oxide; Oxygen radical; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; HUMAN; LYMPHOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031881608     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020497     Document Type: Short Survey

References (34)

1. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7.
2. Jaffer F, Saunders C, Schultz P, Throckmorton D, Weinshell E, Abboud HE: Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta. Am J Pathol 1989;135:261-269.
3. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 1992;41: 1213-1221.
4. Choi ME, Ballermann BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J Biol Chem 1995; 270:21144-21150.
5. Kitamura M, Burton S, English J, Kawachi H, Fine LG: Transfer of a mutated gene encoding active transforming growth factor-β1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 1995;48:1747-1757.
6. Pfeilschifter J, Vosbeck K: Transforming growth factor β2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 1991;175:372-379.
7. 2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells. Biochem J 1996;315:435-441.
8. Danoff TM, Jiang HB: TGF-β1 suppresses the induction of Rantes by TNF-α (abstract). J Am Soc Nephroll 1996;7:1696.
9. Smith WB, Noack L, Khew-Goodall Y, Isenmann S, Vadas MA, Gamble JR: Transforming growth factor-beta I inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J Immunol 1996;157:360-368.
10. Gamble JR, Vadas MA: Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. Science 1988;242: 97-99.
11. Sütö TS, Fine LG, Kitamura M: Mesangial cell-derived transforming growth factor-β1 reduces macrophage adhesiveness with consequent deactivation. Kidney Int 1996;50:445-452.
12. Bottalico LA, Wager RE, Agellon LB, Assoian RK, Tabas I: Transforming growth factor-β1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 1991;266: 22866-22871.
13. Hogasen AK, Hestdal K, Hogasen K, Abrahamsen TG: Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes. J Leukoc Biol 1995;57: 287-296.
14. Kitamura M, Sütö TS, Yokoo T, Shimizu F, Fine LG: Transforming growth factor-β1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996;156:2964-2971.
15. Kitamura M: Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as transforming growth factor-β1. J Immunol (in press).
16. Wahl SM, McCartney-Francis N, Mergenhagen SE: Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 1989;10:258-261.
17. Tsunawaki S, Sporn MB, Ding A, Nathan C: Deactivation of macrophages by transforming growth factor-β. Nature 1988;334:260-262.
18. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S: Macrophage deactivating factor and transforming growth factor-β1, -β2, -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFM-γ. J Immunol 1990; 145:940-944.
19. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
20. Kitamura M, Mitarai T, Nagasawa R, Maruyama N: Differentiated phenotype of glomerular mesangial cells in modular culture. Am J Physiol 1996;270:F614-F622.
21. Kitamura M, Mitarai T, Maruyama N, Nagasawa R, Yoshida H, Sakai O: Mesangial cell behavior in a three-dimensional extracellular matrix. Kidney Int 1991;40:653-661.
22. 6,GG elements (abstract). J Am Soc Nephrol 1996;7: 1757.
23. Kitamura M, Shirasawa T, Maruyama N: Gene transfer of metalloproteinase transin induces aberrant behavior of cultured mesangial cells. Kidney Int 1994;45:1580-1586.
24. Süto TS, Fine LG, Shimizu F, Kitamura M: In vivo transfer of engineered macrophages into the glomerulus: Endogenous TGF-β-mediated "defense" against macrophage-induced glomerular cell activation. J Immunol. in press.
25. Kitamura M, Sütö TS: Transfer of genetically engineered macrophages into the glomerulus. Kidney Int 1997;51:1274-1279.
26. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by anti-serum against transforming growth factor β1. Nature 1990; 346:371-374.
27. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92: 2597-2601.
28. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996;50:148-155.
29. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M, Kipps T, Carson DA: Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 1993;90:4523-4527.
30. Raz E, Dudler J, Lotz M, Baird SM, Berry CC, Eisenberg RA, Carson DA: Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 1995;4:286-292.
31. Qin L, Chavin KD, Ding Y, Woodward JE, Favaro JP, Lin J, Bromberg JS: Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-β1. Ann Surg 1994;220:508-519.
32. Qin L, Ding Y, Bromberg JS: Gene transfer of transforming growth factor-β1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 1996;7: 1981-1988.
33. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annuziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992;359:693-699.
34. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ: Protective effect of transforming growth factor-β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991;88:2918-2921.